Why Are More Younger Adults Developing Alzheimer’s and Dementia?

04-30-20-Early-Dementia-Featured-Image
APRIL 30, 2020
Why Are More Younger Adults Developing Alzheimer’s and Dementia?
By the Children’s Health Defense Team

Why Are More Younger Adults Developing Alzheimer’s and Dementia?

In late February, Blue Cross Blue Shield (BCBS) released a disturbing report describing the growing number of younger American adults diagnosed with early-onset dementia and Alzheimer’s disease (AD). Analyzing the four-year period from 2013-2017, BCBS reported a 200% increase in diagnosed dementia and AD among commercially insured adults from ages 30 to 64. As of 2017, approximately 15% of the insured younger Americans who received one of the two diagnoses were in their thirties or early to mid-forties.

The BCBS results reinforce findings from previous studies. In 2014, UK researchers reported that the number of under-65 individuals developing dementia was “double what was previously thought.” The next year, researchers looking at twenty-year dementia trends in the U.S. and other Western nations reported that dementias were starting “a decade earlier than they used to.”

The downward creep of various types of dementia into younger age groups gives new meaning to the decades-old slogan popularized by the United Negro College Fund that “a mind is a terrible thing to waste.” With initial symptoms that may include “depression, behavioural change, neurological disorders, systemic disorders and mild cognitive impairment,” early-onset dementia can force individuals into early retirement and financial hardship—or worse. An Irish study published in 2019 found that people with young-onset dementia “most commonly die from complications of dementia” versus other illnesses, even though nearly nine in ten also have at least one comorbid disease. BCBS puts it this way: Younger adults living with dementia or AD “are living at just 63% of optimal health—leading to about 11 years of healthy life lost.”

Estimates suggest that while around 11% of young-onset AD cases (and perhaps 1% of Alzheimer’s cases overall) do have a genetic mutation that runs in families, the bulk of younger Alzheimer’s cases do not have a genetic explanation.
Not normal and (mostly) not genetic
The Mayo Clinic notes that while age is a risk factor, dementia is not “a normal part of aging.” This observation is all the more pertinent when considering the individuals who develop dementia in their prime working-age years. As with many other chronic conditions, researchers have tried to pin the blame for rising rates of dementia on genetics—largely without success. Estimates suggest that while around 11% of young-onset AD cases (and perhaps 1% of Alzheimer’s cases overall) do have a genetic mutation that runs in families, the bulk of younger Alzheimer’s cases do not have a genetic explanation.

Moreover, AD is only a small piece of the broader dementia puzzle in those afflicted at younger ages. Whereas the majority—well over half—of older adults (> 65 years) with dementia have AD, Alzheimer’s accounts for only a third of younger dementia cases. (Looked at a different way, just 5% to 6% of all Americans with AD are under age 65.) More frequent forms of dementia in those under 65 include frontotemporal dementia—a nasty condition that produces loss of empathy, disinhibition, apathy, overeating and memory loss—and vascular dementia, which is linked to rampant chronic conditions such as obesity, diabetes and high blood pressure. Interestingly, a growing body of research actually conceptualizes AD as type 3 diabetes or “brain diabetes” because of “molecular and biochemical features that overlap” with diabetes types 1 and 2.

For some researchers, the strong link between neurodegenerative diseases and dementia points to environmental exposures rather than genetics as likely culprits.
If not genetics, then what?
A study published in late 2019 assessed nongenetic risk factors for two types of young-onset dementia, considering a range of risks related to demographics, lifestyle and medical history. The researchers found that nongenetic factors in combination conferred more risk than any single factor, with each additional exposure increasing the risk of midlife dementia by 28%. The authors concluded that some individuals with young-onset dementia “experience a lifetime of risk exposure starting from early in life.”

Still pushing the genetics theme, some researchers have suggested that childhood neurodegenerative conditions presumed to be genetic—such as mitochondrial disorders, enzyme-related disorders and abnormalities of the myelin sheath—sometimes crop up in delayed fashion and manifest as young-onset dementia in adulthood. Of note, other studies have linked abnormal myelin development to “psychopathology” in adolescents and young adults.

For some researchers, the strong link between neurodegenerative diseases and dementia points to environmental exposures rather than genetics as likely culprits. In a twenty-year study (1989-2010) of dementia trends in 55-74 year-old adults across 21 developed countries, the U.S. experienced the biggest increase (82%) in total neurological deaths—defined as “Alzheimer and other dementias” plus “nervous disease” deaths. The U.S. went from a ranking of 17th in 1989 to having the second highest rate of 55-74 year-old dementia by 2010. To explain their dramatic results in both the U.S. and other countries, the lead author pointed a finger at environmental factors:

The rate of increase in such a short time suggests a silent or even a “hidden” epidemic, in which environmental factors must play a major part, not just aging. . . . [T]he changes in human morbidity, including neurological disease is [sic] remarkable and points to environmental influences. [. . .] The environmental changes in the last 20 years have seen increases in the human environment of petro-chemicals—air transport, quadrupling of motor vehicles, insecticides and rises in background electro-magnetic-field, and so on.

Some investigators cite traumatic brain injuries (TBIs)—increasingly common in children and adolescents—as another important contributor to early-onset dementia. In a 2014 paper, Dr. Stephanie Seneff of MIT and lead author Wendy Morley coined the term “diminished brain resilience syndrome” to describe “a modern day neurological pathway of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration.” The two placed the blame for the heightened vulnerability of young brains on multiple environmental and lifestyle factors, including exposure to glyphosate.

In a 2008 JAMA Neurology study of dementia occurring in individuals under age 45—whose average age of onset was 34.7 years—the researchers linked 21% of cases to autoimmune or inflammatory causes, including lupus, autoimmune encephalopathy and multiple sclerosis (MS). Cognitive symptoms, including dementia, are some of the oldest recognized signs of MS—a condition that involves demyelination—with full dementia present in roughly one in five MS patients.

… presents findings that are unequivocal in their confirmation of a role for aluminium in some if not all Alzheimer’s disease.
Let’s not forget aluminum
In the just-mentioned 2008 study in JAMA Neurology, 19% of dementia cases in younger patients were of “unknown etiology, despite exhaustive evaluation” that sometimes included brain biopsy. The researchers made no mention of the known neurotoxin aluminum as a potential contributor—a surprising omission given the 2001 publication of the book Aluminium and Alzheimer’s Disease: The Science that Describes the Link, edited by UK Professor Christopher Exley, one of the world’s foremost aluminum experts. For decades, Exley and colleagues have tried to shine a spotlight on the role of aluminum in Alzheimer’s disease in the face of massive industry pushback and denials.

The latest effort by Professor Exley and his group presents findings that are “unequivocal in their confirmation of a role for aluminium in some if not all Alzheimer’s disease.” The study found unprecedentedly high levels of aluminum in the brain tissue of persons who died with the type of AD associated with genetic mutations (familial AD). Exley speculates that these genetic predispositions may also predispose individuals to accumulate high levels of brain aluminum “at a much younger age.” In other work, Exley has suggested that aluminum may also act as a “catalyst” for earlier-onset AD in people “without concomitant predispositions, genetic or otherwise,” and he proposes viewing AD “as an acute response to chronic intoxication by aluminum.” Professor Exley has also reported on the extraordinarily high levels of aluminum found in autism brain tissue.

Electromagnetic field (EMF) safety advocates have been raising questions for years about the link between cell phones and dementia at younger ages …
Protecting children’s bodies—and minds
Many of the conditions and exposures correlated with early-onset dementia—diabetes, obesity, autoimmune illness, traumatic brain injury, glyphosate poisoning and aluminum intoxication via vaccines—are occurring at epidemic levels in our children. Electromagnetic fields (EMFs) are also a growing concern. The scientific literature already links occupational EMF exposure to early-onset dementia. EMF safety advocates have been raising questions for years about the link between cell phones and dementia at younger ages, particularly because of cell phones’ effects on blood-brain barrier permeability. Clearly, these questions have great significance for the developing brains of our cell-phone-enamored and wireless-saturated children.

Alzheimer’s disease alone is already America’s most expensive disease, costing more than either heart disease or cancer. If we do not turn the chronic disease epidemics around and diminish or eliminate children’s toxic exposures, chances are that the next study of early-onset dementia will present even more troubling results—and there will be fewer adults with the brain power to understand them.

California just passed a law forcing Vaccines on kids – even kids with medical problems circumventing doctors to prevent exemptions

TTAV-Breaking-News-March-Against-sb276

California just passed a law forcing Vaccines on kids – even kids with medical problems circumventing doctors to prevent exemptions

State Senator Richard Pan introduced Senate Bill 276 (SB 276), which will do 3 things:
Give sole power to grant medical exemptions to government officials. These officials will not be required to see the patient or have any medical training.
Restrict the awarding of medical exemptions to only those who fall within the stringent CDC guidelines. The state will have the power to revoke exemptions granted previously under SB277.
Create and maintain a database of all medical exemptions. Since the state health department is not a medical establishment, it will not be prohibited from disclosing this information or sharing it with other government entities.

TTAV-Breaking-News-March-Against-sb276

Under current laws, California doctors may issue a medical exemption for any child that had a medical reason for skipping the vaccines. Doctor discretion varied widely and was not restricted to the stringent CDC guidelines. But many doctors, including Dr. Kenneth Stoller, were persecuted for issuing “too many” medical exemptions. In May, San Francisco City Attorney Dennis Herrera announced that he was investigating Dr. Kenneth Stoller for allegedly writing fraudulent medical exemptions for mandatory childhood vaccinations.
He followed the announcement with a subpoena asking Dr. Stoller to surrender private patient medical records for any of his patients seeking a medical exemption, citing “state nuisance” laws. Dr. Stoller fought back, protecting both his authority as a physician and the privacy rights of his patients. But SB 276 will change all that.
It seems apparent that the bill was designed for the dual purposes of
1) transferring exemption authority from doctors to the state and
2) creating a vaccination database to track the records of all Californians.

SB 276: California Passes New Restrictive Vaccine Laws… Who’s Really Calling the Shots?

TTAV-Breaking-News-March-Against-sb276

From Liberty Beacon: Dr. Offit, and Bill Gates, Purveyors of Misery Death Through Vaccines

Two Famous Purveyors of Misery & Death Through Vaccines
Posted by: TLB Staff
Published May 8, 2015, filed under HEALTH
http://www.thelibertybeacon.com/2015/05/08/two-famous-purveyors-of-misery-death-through-vaccines/


Vaccine run
Courtesy the Liberty Beacon
By TLB Contributor: PAUL FASSA

Dr. Paul Offit, the premier vaccine promoter and spokesperson, is not necessarily a media darling, but he gets lots of favorable press and gets passes on anything he says no matter how ridiculous. Then there is Bill Gates who was once criticized for not being philanthropic and has since changed to … ? What are Bill and Melinda really promoting with their vaccination programs.

Starting with Offit, he has profited from anywhere to 30 to 45 million or more for his involvement with creating and patenting the most current rotovirus vaccine, RotaTeq. Rotovirus is considered the viral source of intense, potentially lethal diarrhea in infants and young children.

He also put himself in position with the CDC, as a member of the Advisory Committee on Immunization Practices (ACIP) to help create the market for his rotavirus vaccine – effectively voting himself rich to have it approved as part of the CDC’s vaccine “recommended” schedule for infants and young children.

RotaTeq in France

317595_10151414335738998_2142287379_n

Paul Offit’s RotaTeq is administered to the newly born. France’s Directorate General of Health received a report from Technical Committee of Pharmacovigilance that cited at least two infant deaths recorded from RotaTeq along with 508 adverse side effect events of which 201 were considered serious since 2007. Serious probably means life-long debilitation of some sort.

This all boils down to France’s medical bureaucrats wondering if the RotaTeq vaccine should be part of a mandated vaccination schedule. But declining royalties won’t hurt Offit. He grabbed his estimated $40 million for the Children’s Hospital of Philadelphia’s (CHOP) $180 million dollar sale of the royalty rights.

But according to Age of Autism’s thorough analysis of the obscurely hidden financial machinations involving the royalty rights sales to investment companies, it appears that Offit and his two co-inventors have been and will be continuing to share 15% of Merck’s international sale royalties until the patents expire in 2019.

The Age of Autism’s in depth analysis, “Counting Offit’s Millions: More on How Merck’s Rotateq Vaccine Made Paul Offit Wealthy” is an eye-opening disclosure of the economics of the vaccine industry.


Vac-Baby

Merck is the manufacturer of this vaccine, and Offit is also paid as a PR representative for them.He has written several books promoting vaccines and has publicly stated babies could withstand 10,000 vaccinations in a day without harm. He later changed it to a thousand from 10,000.

Offit has also claimed the aluminum adjuvants used in vaccines are great for helping the fetus develop in pregnant women. There have been hundreds of miscarriages and still births reported by women who had been vaccinated during pregnancy, as “recommended” by the CDC. Offit is one of the most celebrated and respected medical authorities in mainstream media. So you see what kind of crap we’re up against.

Shifting to a True Mainstream Darling – Bill Gates and His Vaccination Campaigns

Ah yes, Bill Gates, the harmless geeky “genius” who has many under his spell. He is responsible for countless deaths and countable cases of NPAFP (non-polio acute flaccid paralysis), 47,500 cases in 2011 alone.

Non-polio AFP is clinically similar to wild virus polio, except it is more lethal and comes from the live virus in oral polio vaccine (OPV), which was finally banned in the USA and UK because it was causing polio to those who drank it while they in turn infected others via viral shedding.


bill_gates_47500_cases_paralysis_india

But hey, gotta make money. So peddle OPVs to third world countries and get a buyer to provide them. The buyers are usually governments and international agencies such as the UN or WHO. But occasionally a third party investor steps in as a philanthropic gesture. Now enters Bill Gates.

Gates is on record in saying that “people who engage in anti-vaccine efforts kill children.” But in a video recorded live lecture, Gates mentioned how the proper strategy of vaccinations could result in a 15 percent population decrease. That statement appears just before the end of this clip.

Most considered that a slip of the tongue, one that was never amended by Gates, who usually pathetically worms himself out of tight spots like a cornered nebish (a person cute in a dorky sort of way). That usually fools most fools that comprise the bulk of our population.

By the way, Gates did not completely foot the bill for vaccinating so many children in India with OPVs. He pitched in with UNICEF and the WHO to kick start the “eradicate polio in India” campaign. Once it was started, Gates became a lead lobbyist urging the Indian government to foot the enormous bill of vaccinating 170 million children five years of age and younger.

The 47,500 cases of non-polio AFP, 12 fold higher than normal and coinciding within the time frame OPV doses were administered, was from a report published in the Indian Journal of Medical Ethics. And more cases may have started since 2011 from vaccine shedding by those vaccinated.

So how come Gates isn’t aware of this anomaly of so many coming down with polio symptoms that are worse than regular wild polio while boasting that now India is polio free? Well, change the name and the original disease no longer exists. Instead of polio it’s polio like diseases, like non-polio acute flaccid paralysis (AFP), which is even more lethal than wild polio paralysis.

But the press raves about how polio has been eliminated in India. Perfect PR trickery to cover-up the tragic consequences of this vast vaccination campaign

Looks like Gates is on the road to dropping the world’s population by 15 percent with strategic vaccination campaigns. How much more will occur from Monsanto, in which Gates is heavily invested and campaigning for third world acceptance, remains to be seen.

Paul Fassa is a contributing staff writer for REALfarmacy.com and The Liberty Beacon project. His pet peeves are the Medical Mafia’s control over health and the food industry and government regulatory agencies’ corruption. Paul’s valiant contributions to the health movement and global paradigm shift are world renowned. Visit his blog by following this link and follow him on Twitter here.

Sources:

http://articles.mercola.com/sites/articles/archive/2009/06/25/vaccine-doctor-given-at-least-30-million-dollars-to-push-vaccines.aspx

http://www.thelocal.fr/20150401/two-babies-die-in-france-after-vaccination

http://www.ageofautism.com/2011/01/counting-offits-millions-more-on-how-mercks-rotateq-vaccine-made-paul-offit-wealthy.html

Bill Gates’ Polio Vaccine Program Caused 47,500 Cases of Paralysis Death

http://articles.mercola.com/sites/articles/archive/2012/08/28/polio-eradication-campaign.aspx

Image Sources:

https://sp.yimg.com/ib/th?id=JN.m5jb27RkOAhjv3FcL4JmyA&pid=15.1&P=0

http://static.infowars.com/2012/04/i/general/bill_gates_47500_cases_paralysis